Menu

InspireMD, Inc. NSPR

Full chart Compare
Set alert

Price alert · NSPR

All alert types
0.62 USD -0.02 (-2.82%)

Nov 6, 2026, 9:53 AM EST

0.621 Day range 0.6492
0.43 52-week range 2.22
YTD
-65.11%
1 year
-68.32%

Revenue & Expenses

Revenue by
Other Income → Expenses: $389.00KOther Countries → Revenue: $4.06MOther Operating Income → Expenses: $502.00KUnited States → Revenue: $1.42MExpenses → Selling, General & Admin: $37.26MExpenses → Research & Development: $15.00MExpenses → Income Tax: $63.00KGross Profit → Expenses: $2.65MRevenue → Gross Profit: $2.65MRevenue → Cost of Revenue: $6.33MGermany → Revenue: $1.23MNet Loss → Expenses: $48.79MItaly → Revenue: $1.23MPoland → Revenue: $1.04MOther Income$389.00KOther Operating Income$502.00KGross Profit$2.65MNet Loss$48.79MCost of Revenue$6.33MExpenses$52.33MSelling, General & Admin$37.26MResearch & Development$15.00MIncome Tax$63.00KRevenue$8.98MOther Countries$4.06MUnited States$1.42MGermany$1.23MItaly$1.23MPoland$1.04M

Latest period ending Dec 31, 2025 · select a line to chart its full history

NSPR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
8.98M7.01M6.21M5.17M4.50M
2.65M1.51M1.81M1.12M754.00K
-49.61M-33.50M-21.14M-18.71M-14.72M
-48.79M-32.01M-19.92M-18.49M-14.92M
-0.76-0.76-0.82-2.35-2.03
NSPR annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
8.94M18.92M9.64M4.63M12.00M
69.40M46.81M47.64M24.65M39.71M
14.20M10.72M8.14M7.26M6.18M
2.22M1.80M1.04M1.20M781.00K
55.20M36.09M39.50M17.39M33.53M
NSPR annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-35.10M-21.87M-16.38M-15.54M-13.21M
-30.56M12.64M-16.09M8.44M-22.46M
55.57M18.45M37.53M-140.00K35.03M
-1.65M-1.40M-369.00K-473.00K-344.00K
-9.98M9.28M5.01M-7.37M-641.00K